Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Padding Of Continuing Resolution Bill Could Trigger Government Shutdown

This article was originally published in The Gray Sheet

Executive Summary

A device tax repeal, delay of the Affordable Care Act’s individual mandate, or any other amendment the House decides to attach to a Sept. 27 Senate-approved, amendment-free continuing resolution bill would lead to a government shutdown, Senate leaders warn, noting there would not be enough time left before the end of the current fiscal year, Sept. 30, for the Senate to revisit a modified bill and approve whatever changes the House makes to it.

You may also be interested in...



Doc Pay Bill Faces Rough Waters With $175 Billion Price Tag

Even in the best of congressional spending climates, finding an estimated $138 billion to cover a proposed permanent fix for the sustainable growth formula would be difficult. But with the Congressional Budget Office’s recent $175 billion scoring of House legislation, and House Republicans threatening a government shutdown if deficit targets for FY 2014 are not met, it may be impossible.

Second EU MDR Notified Body Designated In France

Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.

Takeda, Astellas Found New JV To Support Japanese Bioventures

Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT032443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel